Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Identify which index fund to hold after IRA rollover 2024 by weighing cost, simplicity, and diversification. Get practical guidance for a solid retirement stance.
26,517 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A widow learns her husband’s survivor election was misfiled, triggering a $146,000 gap in benefits. Officials say mos...
A regulatory milestone sparked a notable move for Oklo shares, highlighting how news on licensing can lift niche ener...
When a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
A growing claim about Chrome downloads a 4GB AI model and quietly reinstalls it if deleted. This article explains wha...
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...
A growth stock has fallen sharply, trading hands at levels that look oversold. This article breaks down whether the d...
Nvidia just delivered another earnings beat and a bold $80 billion buyback. As AI infrastructure spending accelerates...
Jim Cramer says he is watching Marvell after Jensen Huang’s trillion-dollar endorsement, making the AI hardware name ...
Rigetti Computing just landed $100 million in CHIPS Act funding. This article breaks down what that means for the com...
SpaceX stock SPCX rebounds after a three-day selloff, with traders awaiting new catalysts as analysts weigh long-term...
As spacex insider lockups start, investors watch for how staged unlocks could affect liquidity and volatility. This a...